BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Return 108.35%
This Quarter Return
+12.09%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.04B
AUM Growth
+$139M
Cap. Flow
+$211M
Cap. Flow %
10.36%
Top 10 Hldgs %
52.83%
Holding
78
New
7
Increased
4
Reduced
2
Closed
3

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$107M
2
SGEN
Seagen Inc. Common Stock
SGEN
$40.5M
3
ELVN icon
Enliven Therapeutics
ELVN
$15.6M
4
RVMD icon
Revolution Medicines
RVMD
$15.2M
5
IOVA icon
Iovance Biotherapeutics
IOVA
$13.4M

Top Sells

1
GERN icon
Geron
GERN
$19.6M
2
ARVN icon
Arvinas
ARVN
$5.13M
3
FATE icon
Fate Therapeutics
FATE
$4.28M
4
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$577K
5
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
$41K

Sector Composition

1 Healthcare 99.75%
2 Financials 0.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FOLD icon
26
Amicus Therapeutics
FOLD
$2.46B
$25.8M 1.27%
2,325,000
– –
RCKT icon
27
Rocket Pharmaceuticals
RCKT
$354M
$25.1M 1.23%
1,466,051
– –
AXSM icon
28
Axsome Therapeutics
AXSM
$6.25B
$24.7M 1.21%
400,000
– –
BLU
29
DELISTED
BELLUS Health Inc.
BLU
$23M 1.13%
3,200,000
– –
IOVA icon
30
Iovance Biotherapeutics
IOVA
$901M
$22.6M 1.11%
3,705,133
+2,200,000
+146% +$13.4M
EXEL icon
31
Exelixis
EXEL
$10.2B
$22.3M 1.1%
1,150,000
– –
XENE icon
32
Xenon Pharmaceuticals
XENE
$3.02B
$21.5M 1.05%
600,000
– –
ISEE
33
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$20.1M 0.99%
825,000
– –
RAIN
34
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$18.8M 0.92%
2,147,212
– –
PNT
35
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$18.2M 0.89%
2,500,000
– –
RNA icon
36
Avidity Biosciences
RNA
$6.48B
$17.2M 0.85%
1,121,327
– –
DAWN icon
37
Day One Biopharmaceuticals
DAWN
$773M
$15.9M 0.78%
1,189,943
– –
ELVN icon
38
Enliven Therapeutics
ELVN
$1.19B
$15.6M 0.76%
+710,644
New +$15.6M
PMVP icon
39
PMV Pharmaceuticals
PMVP
$77.4M
$15.1M 0.74%
3,163,795
– –
PRTA icon
40
Prothena Corp
PRTA
$460M
$14.5M 0.71%
300,000
– –
KALV icon
41
KalVista Pharmaceuticals
KALV
$796M
$13M 0.64%
+1,650,000
New +$13M
CGEM icon
42
Cullinan Oncology
CGEM
$413M
$11M 0.54%
1,074,082
– –
NRIX icon
43
Nurix Therapeutics
NRIX
$758M
$10.9M 0.53%
1,224,892
– –
ASND icon
44
Ascendis Pharma
ASND
$12.5B
$10.2M 0.5%
95,000
– –
MORF
45
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$7.53M 0.37%
+200,000
New +$7.53M
ORIC icon
46
Oric Pharmaceuticals
ORIC
$1.06B
$6.01M 0.3%
1,054,000
– –
COGT icon
47
Cogent Biosciences
COGT
$1.82B
$5.67M 0.28%
525,000
– –
RAPT icon
48
RAPT Therapeutics
RAPT
$214M
$5.51M 0.27%
+37,500
New +$5.51M
PANA
49
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$5.11M 0.25%
500,000
– –
OBIO icon
50
Orchestra BioMed
OBIO
$148M
$4.89M 0.24%
250,000
– –
1
2
3 4